- Patent Title: Indoleamine 2,3-dioxygenase inhibitors and use of same in medicine
-
Application No.: US16914142Application Date: 2020-06-26
-
Publication No.: US11111230B2Publication Date: 2021-09-07
- Inventor: Pan Li , Qiaodong Wen , Ji Wang , Quan Gan , Yang Lu , Donghui Yang
- Applicant: ADLAI NORTYE BIOPHARMA CO., LTD.
- Applicant Address: CN Zhejiang
- Assignee: ADLAI NORTYE BIOPHARMA CO., LTD.
- Current Assignee: ADLAI NORTYE BIOPHARMA CO., LTD.
- Current Assignee Address: CN Zhejiang
- Agency: Hoxie & Associates LLC
- Priority: CN201711478307.2 20171229,CN201810754253.6 20180629
- Main IPC: C07D215/14
- IPC: C07D215/14 ; C07D401/12 ; C07D401/08 ; C07D405/08 ; C07D409/12
Abstract:
The present invention relates to a compound represented by formula I, a pharmaceutical composition containing the compound of formula I, a method for inhibiting indoleamine 2,3-dioxygenase, and its use in medicine.
Public/Granted literature
- US20200331887A1 INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS AND USE OF SAME IN MEDICINE Public/Granted day:2020-10-22
Information query
